Replies to post #177591 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Any clinical excitement seems to me to be years away.

[CkFacts]

Could be Skyhawk Therapeutics , launched January 2018 : Novel Platform of small molecules that correct RNA expression . Specific areas Alzheimer’s and Cancer research.

Kevin Koch , co- founder , previously with Biogen

Dr. Friedrich Metzger, founding chairman of Skyhawk scientific board , also an advisor to Anavex board and is / was senior Assoc Editor for Journal of Alzheimers and Dementia .

Biogen connection , part of the iceberg ?

2019 , twelve years since start of Anavex growth - - should be a great year , full of lots of “ ahaa “ moments .

Keep up the great contributions and D D longs : Bio , falconer , Talon , Zenia , Nidan , tred , Georgii , et al

GLTAL